4//SEC Filing
T2 Biosystems, Inc. 4
Accession 0001104659-14-061090
CIK 0001492674operating
Filed
Aug 13, 8:00 PM ET
Accepted
Aug 14, 4:34 PM ET
Size
19.7 KB
Accession
0001104659-14-061090
Insider Transaction Report
Form 4
AISLING CAPITAL III LP
10% Owner
Transactions
- Purchase
Common Stock
2014-08-12$11.00/sh+454,545$4,999,995→ 2,523,300 total(indirect: See footnote) - Conversion
Common Stock
2014-08-12+2,068,755→ 2,068,755 total(indirect: See footnote) - Conversion
Series E Convertible Preferred Stock
2014-08-12−549,851→ 0 total(indirect: See footnote)Exercise: $0.00→ Common Stock (323,441 underlying) - Conversion
Series D Convertible Preferred Stock
2014-08-12−2,967,033→ 0 total(indirect: See footnote)Exercise: $0.00→ Common Stock (1,745,313 underlying)
SCHIFF ANDREW N
10% Owner
Transactions
- Conversion
Common Stock
2014-08-12+2,068,755→ 2,068,755 total(indirect: See footnote) - Purchase
Common Stock
2014-08-12$11.00/sh+454,545$4,999,995→ 2,523,300 total(indirect: See footnote) - Conversion
Series D Convertible Preferred Stock
2014-08-12−2,967,033→ 0 total(indirect: See footnote)Exercise: $0.00→ Common Stock (1,745,313 underlying) - Conversion
Series E Convertible Preferred Stock
2014-08-12−549,851→ 0 total(indirect: See footnote)Exercise: $0.00→ Common Stock (323,441 underlying)
Purcell Dennis J
10% Owner
Transactions
- Conversion
Common Stock
2014-08-12+2,068,755→ 2,068,755 total(indirect: See footnote) - Conversion
Series D Convertible Preferred Stock
2014-08-12−2,967,033→ 0 total(indirect: See footnote)Exercise: $0.00→ Common Stock (1,745,313 underlying) - Purchase
Common Stock
2014-08-12$11.00/sh+454,545$4,999,995→ 2,523,300 total(indirect: See footnote) - Conversion
Series E Convertible Preferred Stock
2014-08-12−549,851→ 0 total(indirect: See footnote)Exercise: $0.00→ Common Stock (323,441 underlying)
ELMS STEVE
10% Owner
Transactions
- Conversion
Common Stock
2014-08-12+2,068,755→ 2,068,755 total(indirect: See footnote) - Purchase
Common Stock
2014-08-12$11.00/sh+454,545$4,999,995→ 2,523,300 total(indirect: See footnote) - Conversion
Series D Convertible Preferred Stock
2014-08-12−2,967,033→ 0 total(indirect: See footnote)Exercise: $0.00→ Common Stock (1,745,313 underlying) - Conversion
Series E Convertible Preferred Stock
2014-08-12−549,851→ 0 total(indirect: See footnote)Exercise: $0.00→ Common Stock (323,441 underlying)
Aisling Capital Partners III LLC
10% Owner
Transactions
- Conversion
Common Stock
2014-08-12+2,068,755→ 2,068,755 total(indirect: See footnote) - Purchase
Common Stock
2014-08-12$11.00/sh+454,545$4,999,995→ 2,523,300 total(indirect: See footnote) - Conversion
Series D Convertible Preferred Stock
2014-08-12−2,967,033→ 0 total(indirect: See footnote)Exercise: $0.00→ Common Stock (1,745,313 underlying) - Conversion
Series E Convertible Preferred Stock
2014-08-12−549,851→ 0 total(indirect: See footnote)Exercise: $0.00→ Common Stock (323,441 underlying)
Aisling Capital Partners III LP
10% Owner
Transactions
- Conversion
Common Stock
2014-08-12+2,068,755→ 2,068,755 total(indirect: See footnote) - Conversion
Series E Convertible Preferred Stock
2014-08-12−549,851→ 0 total(indirect: See footnote)Exercise: $0.00→ Common Stock (323,441 underlying) - Purchase
Common Stock
2014-08-12$11.00/sh+454,545$4,999,995→ 2,523,300 total(indirect: See footnote) - Conversion
Series D Convertible Preferred Stock
2014-08-12−2,967,033→ 0 total(indirect: See footnote)Exercise: $0.00→ Common Stock (1,745,313 underlying)
Footnotes (2)
- [F1]The preferred stock is convertible at any time, at the holder's election and has no expiration date. The preferred stock automatically converted into common stock upon the closing of the Issuer's initial public offering.
- [F2]The reportable securities are owned directly by Aisling Capital III, LP ("Aisling"), and held indirectly by Aisling Capital Partners III, LP ("Aisling GP"), as general partner of Aisling, Aisling Capital Partners III LLC ("Aisling Partners"), as general partner of Aisling GP, and each of the individual managing members of Aisling Partners. The individual managing members (collectively, the "Managers") of Aisling Partners are Dennis Purcell, Dr. Andrew Schiff and Steve Elms. Aisling GP, Aisling Partners and the Managers share voting and dispositive power over the shares directly held by Aisling.
Documents
Issuer
T2 Biosystems, Inc.
CIK 0001492674
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001492674
Filing Metadata
- Form type
- 4
- Filed
- Aug 13, 8:00 PM ET
- Accepted
- Aug 14, 4:34 PM ET
- Size
- 19.7 KB